High expression of NPY receptors in the human testis

Meike Körner1, Beatriche Waser, George N Thalmann

  • 1Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Berne, Switzerland.

Insights

Neuropeptide Y (NPY) receptors are expressed in normal human testes, particularly in Leydig cells (Y2) and blood vessels (Y1). This suggests the testis is a key physiological and pharmacological target for NPY system research.

Area of Science:

  • Endocrinology
  • Reproductive Biology
  • Molecular Pharmacology

Background:

  • Neuropeptide Y (NPY) receptors are emerging therapeutic targets for cancer and obesity.
  • Limited data exists on NPY receptor expression in normal human tissues.
  • NPY plays a known role in reproductive functions.

Purpose of the Study:

  • To investigate NPY receptor expression in normal human testes and testicular tumors.
  • To determine the functional status of NPY receptors in the testis.
  • To assess the potential of the human testis as an NPY target.

Main Methods:

  • NPY receptor autoradiography on 25 normal testes and 24 testicular tumors.
  • Agonist-stimulated [(35)S]GTPγS binding autoradiography to assess receptor functionality.
  • Immunohistochemistry to detect NPY peptide in testicular tissues.

Main Results:

  • Normal testes showed strong Y2 receptor expression in Leydig cells and Y1 in arterial blood vessels.
  • Y2 receptors in the testis were confirmed as functional.
  • NPY peptide was detected in nerve fibers near Leydig cells and arteries.
  • Testicular germ cell tumors expressed Y1 and Y2 receptors on tumor cells (33%) and Y1 on intratumoral vessels (50%).

Conclusions:

  • The normal human testis exhibits significant NPY receptor expression, particularly Y2 in Leydig cells and Y1 in blood vessels.
  • The NPY system is functionally intact within the normal testis.
  • These findings highlight the human testis as a potential physiological and pharmacological target for NPY-related interventions.